Weight-Adjusted Hydroxychloroquine and Azithromycin Boosted Survival of Ventilated COVID-19 Patients by 200 Percent: Study
“We found that when the cumulative doses of two drugs, HCQ and AZM, were above a certain level, patients had a survival rate 2.9 times the other patients,” the authors of the study noted.